Published in Cell Mol Neurobiol on November 15, 2014
Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches. Cell Mol Immunol (2016) 0.77
Stem cell transplantation therapy for multifaceted therapeutic benefits after stroke. Prog Neurobiol (2017) 0.75
Comparison of MSC-Neurogenin1 administration modality in MCAO rat model. Transl Neurosci (2016) 0.75
Microcirculatory Response In Vivo on Local Intraarterial Infusion of Autogenic Adipose-derived Stem Cells or Stromal Vascular Fraction. Plast Reconstr Surg Glob Open (2016) 0.75
Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia. Sci Rep (2017) 0.75
Clumping and Viability of Bone Marrow Derived Mesenchymal Stromal Cells under Different Preparation Procedures: A Flow Cytometry-Based In Vitro Study. Stem Cells Int (2016) 0.75
Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke (2001) 6.61
Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci (2009) 4.03
Cell transplantation therapy for stroke. Stroke (2007) 2.30
Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain (2011) 2.27
Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci (2001) 2.20
Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke (2008) 2.18
Stem Cell Therapies as an Emerging Paradigm in Stroke (STEPS): bridging basic and clinical science for cellular and neurogenic factor therapy in treating stroke. Stroke (2008) 2.08
Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology (2001) 2.02
Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair. Stem Cells (2011) 1.54
Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain (2006) 1.46
Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke (2010) 1.37
Stem cell research in stroke: how far from the clinic? Stroke (2011) 1.37
Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci (2008) 1.33
Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats. Neuroscience (2010) 1.20
Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. J Neurochem (2012) 1.18
Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods (2011) 1.16
Evidence for high translational potential of mesenchymal stromal cell therapy to improve recovery from ischemic stroke. J Cereb Blood Flow Metab (2013) 1.13
Intra-arterial injection of neural stem cells using a microneedle technique does not cause microembolic strokes. J Cereb Blood Flow Metab (2010) 1.09
Intravascular cell replacement therapy for stroke. Neurosurg Focus (2008) 1.07
Mouse model of focal cerebral ischemia using endothelin-1. J Neurosci Methods (2008) 1.06
The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke (2011) 1.05
Cell size and velocity of injection are major determinants of the safety of intracarotid stem cell transplantation. J Cereb Blood Flow Metab (2013) 1.04
Stem cell therapy for cerebral ischemia: from basic science to clinical applications. J Cereb Blood Flow Metab (2012) 1.03
Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation. Stroke (2012) 1.03
Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. Stroke (2013) 0.97
Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke (2013) 0.95
The rise of cell therapy trials for stroke: review of published and registered studies. Stem Cells Dev (2013) 0.95
Stem cell therapy in ischemic stroke: role of IV and intra-arterial therapy. Neurology (2012) 0.92
Adhesion and incorporation of lacZ-transduced endothelial cells into the intact capillary wall in the rat. Proc Natl Acad Sci U S A (1992) 0.90
Human bone marrow mesenchymal stem/stromal cells produce efficient localization in the brain and enhanced angiogenesis after intra-arterial delivery in rats with cerebral ischemia, but this is not translated to behavioral recovery. Behav Brain Res (2013) 0.89
Efficacy and dose-dependent safety of intra-arterial delivery of mesenchymal stem cells in a rodent stroke model. PLoS One (2014) 0.88
Ischemic brain injury: a consortium analysis of key factors involved in mesenchymal stem cell-mediated inflammatory reduction. Arch Biochem Biophys (2013) 0.84
Engraftment of human mesenchymal stem cells in a rat photothrombotic cerebral infarction model : comparison of intra-arterial and intravenous infusion using MRI and histological analysis. J Korean Neurosurg Soc (2013) 0.83
Endovascular restorative neurosurgery: a novel concept for molecular and cellular therapy of the nervous system. Neurosurgery (2003) 0.82